<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04530851</url>
  </required_header>
  <id_info>
    <org_study_id>103/2562</org_study_id>
    <nct_id>NCT04530851</nct_id>
  </id_info>
  <brief_title>Compare Outcome of Enhanced Recovery After Cesarean Surgery and Conventional Care</brief_title>
  <official_title>Compare Outcome of Enhanced Recovery After Cesarean Surgery and Conventional Care in Rajavithi Hospital</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Rajavithi Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Rajavithi Hospital</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Research objective to compare outcome(Length of stay, pain score, opioid drug use, Bowel&#xD;
      function and complication ) of ERAS protocol and conventional care in pregnant women after&#xD;
      elective cesarean section in Rajavithi hospital.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Research design is Randomized control trial. The pregnant women who go to elective cesarean&#xD;
      section don't know the allocation. The group of ERAS protocol was separated from Conventional&#xD;
      care in patient care unit.&#xD;
&#xD;
      The Pregnant are randomly in two group. In the ERAS group the pregnant receive the the&#xD;
      intervention for preoperative care(Counselin, H2- antagonist and metroclopramide for prevent&#xD;
      aspiration, Drink clear liquid until 2 hour before surgery), Intraoperative care (first&#xD;
      generation cephalosporin in 60 minute before surgery, Clorhexidine for skin cleansing and&#xD;
      Povidine for vaginal cleansing, regional anesthesia, keep warming, blunt expansion of uterine&#xD;
      incision, do not peritoneal suture and subcuticular suture if less than 2 cm, local wound&#xD;
      anesthesia.), post operative care ( Paracetamol and NSAIDs for for pain control, early remove&#xD;
      catheter and ambulation, 5-HT3 antagonist for prevent nausea)&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">January 15, 2020</start_date>
  <completion_date type="Actual">July 30, 2020</completion_date>
  <primary_completion_date type="Actual">July 30, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Compare length of stay of pregnant women after Cesarean section between ERAS protocol and conventional care</measure>
    <time_frame>1 year</time_frame>
    <description>The primary outcome is length of stay (Day)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Compare pain of pregnant women after Cesarean section between ERAS protocol and conventional care</measure>
    <time_frame>1 year</time_frame>
    <description>The outcome is pain score (visual analogue scale )</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Compare opioid use of pregnant women after Cesarean section between ERAS protocol and conventional care</measure>
    <time_frame>1 year</time_frame>
    <description>The outcome are opioid use (Meperidine, Tramadol, Morphine)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Compare complication of pregnant women after Cesarean section between ERAS protocol and conventional care</measure>
    <time_frame>1 year</time_frame>
    <description>The outcome are complication after surgery such as fever, wound infection, wound dehiscence, metritis</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Compare bowel function of pregnant women after Cesarean section between ERAS protocol and conventional care</measure>
    <time_frame>1 year</time_frame>
    <description>The outcome is time to passing gas after surgery(hour)</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">80</enrollment>
  <condition>To Determine Whether ERAS Can Reduce Length of Stay in Pregnant Women After Cesarean Section</condition>
  <arm_group>
    <arm_group_label>Conventional care</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>This group is conventional care of pregnant women after Cesarean section</description>
  </arm_group>
  <arm_group>
    <arm_group_label>ERAS protocol</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>This protocol for improve outcome of pregnant women after Cesarean section</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>ERAS</intervention_name>
    <description>Counseling&#xD;
H2- antagonist and metroclopramide for prevent aspiration&#xD;
Drink clear liquid until 2 hour before surgery&#xD;
First generation cephalosporin in 60 minute before surgery&#xD;
Clorhexidine for skin cleansing and Povidine for vaginal cleansing&#xD;
Regional anesthesia&#xD;
Keep warming&#xD;
Blunt expansion of uterine incision&#xD;
Do not peritoneal suture and subcuticular suture if less than 2 cm&#xD;
Local wound anesthesia.&#xD;
Paracetamol and NSAIDs for for pain control&#xD;
Early remove catheter and ambulation&#xD;
5-HT3 antagonist for prevent nausea</description>
    <arm_group_label>ERAS protocol</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Pregnant women who scheduled for elective Cesarean section at Rajavithi Hospital&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Pregnant women who has preeclampsia with severe feature&#xD;
&#xD;
          -  Pregnant women who has diabetes mellitus with uncontrolled blood sugar&#xD;
&#xD;
          -  Pregnant women who has blood loss &gt; 1,500 ml after surgery&#xD;
&#xD;
          -  Pregnant women who has chrioamnionitis.&#xD;
&#xD;
          -  Pregnant women who has severe medical disease&#xD;
&#xD;
          -  Pregnant women who has BMI &gt;= 40 kg/m2&#xD;
&#xD;
          -  Pregnant women who has placenta adherence.&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Rajavithi hospital</name>
      <address>
        <city>Bangkok</city>
        <zip>10400</zip>
        <country>Thailand</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Thailand</country>
  </location_countries>
  <verification_date>August 2020</verification_date>
  <study_first_submitted>August 25, 2020</study_first_submitted>
  <study_first_submitted_qc>August 25, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">August 28, 2020</study_first_posted>
  <last_update_submitted>August 25, 2020</last_update_submitted>
  <last_update_submitted_qc>August 25, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">August 28, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>ERAS</keyword>
  <keyword>Cesarean section</keyword>
  <keyword>Length of stay</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

